Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias
Clinical Scorecard: The Relationship Between Air Pollution and Dementias Associated with Lewy Bodies and Parkinson's Disease
At a Glance
Category Detail
Condition Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD) Key Mechanisms Long-term exposure to air pollutants (PM2.5 and NO2) may increase neuroimmune response and oxidative stress, contributing to neurodegeneration. Target Population Individuals aged 65 to 95 years living in Denmark. Care Setting Hospital and secondary care settings.
Key Highlights
PD is the fastest increasing neurodegenerative disease worldwide. PDD and DLB account for up to one-quarter of dementia cases globally. Long-term exposure to PM2.5 linked to increased hospitalization risk in DLB and PDD. Air pollutants can cross the blood-brain barrier and exacerbate neurodegenerative conditions. Case-control study design enhances statistical efficiency for rare conditions. Guideline-Based Recommendations
Diagnosis
Use ICD-10 codes G31.8E for DLB and F02.3 for PDD for diagnosis. Management
Consider environmental factors in the management of DLB and PDD. Monitoring & Follow-up
Monitor long-term exposure to air pollutants in at-risk populations. Risks
Increased risk of hospitalization associated with long-term exposure to PM2.5 and NO2. Patient & Prescribing Data
Older adults aged 65-95 with DLB or PDD.
Focus on mitigating environmental exposure to air pollutants as part of treatment strategies.
Clinical Best Practices
Incorporate assessment of air quality in patient evaluations. Educate patients on the potential risks of air pollution related to neurodegenerative diseases. Related Resources & Content
